Oxidized BAL fluid proteins in patients with interstitial lung diseases

Oxygen-derived free radicals, released by phagocytic cells, have been postulated to contribute to lung tissue damage. We therefore investigated oxidative damage to proteins from bronchoalveolar lavage fluid (BALF) as an indicator of oxidative stress and to assess antioxidant defences in the lungs. We examined BAL fluids from patients with interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF, nonsmokers (NS) and smokers (S)), sarcoidosis (SARC, nonsmokers), and asbestosis (ASB, ex-smokers (EXS)). The oxidation of BALF proteins is accompanied by the introduction of carbonyl groups into their amino acid side-chains and can be quantitated by labeling these groups with tritiated borohydride. The total lung content of oxidized proteins recovered by bronchoalveolar lavage (BAL) was 0.3 +/- 0.07 nmol carbonyl.mL-1 BALF (mean +/- SEM) in the NS control group (n = 9) and tended to be increased, in the asymptomatic S group (n = 8; 0.59 +/- 0.14 nmol.mL-1). This parameter was significantly elevated both in IPF-NS (n = 14; 0.84 +/- 0.2 nmol carbonyl.mL-1 BALF) and SARC-NS (n = 15; 0.73 +/- 0.16 nmol.mL-1) as compared with the NS control. On the contrary, in smoking patients with IPF (n = 6; 0.41 +/- 0.1 nmol carbonyl.mL-1 BALF) and also in ASB-EXS (n = 6; 0.37 +/- 0.06 nmol.mL-1) it was not different from NS controls. The total amount of oxidized proteins correlated positively with the absolute number of eosinophils (EOS) in IPF-NS, IPF-S and SARC, and also with absolute polymorphonuclear neutrophil (PMN) numbers in IPF-NS and IPF-S. In conclusion, oxidative damage of BALF proteins occurred in nonsmoking patients with IPF and SARC. The amount of oxidized bronchoalveolar lavage fluid protein may provide a quantitative assessment of oxygen burden, a balance between oxidant stress and antioxidant defences.

This article has been cited by other articles:

				Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, and U. Costabel Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis Eur. Respir. J., May 1, 2008; 31(5): 1030 - 1036. [Abstract] [Full Text] [PDF]

				W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, and P. Gorski Eicosanoids in Exhaled Breath Condensate and BAL Fluid of Patients With Sarcoidosis Chest, August 1, 2007; 132(2): 589 - 596. [Abstract] [Full Text] [PDF]

				E. S. Chen and D. R. Moller Expression Profiling in Granulomatous Lung Disease Proceedings of the ATS, January 1, 2007; 4(1): 101 - 107. [Abstract] [Full Text] [PDF]

				K Nagai, T Betsuyaku, T Kondo, Y Nasuhara, and M Nishimura Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid Thorax, June 1, 2006; 61(6): 496 - 502. [Abstract] [Full Text] [PDF]

				E. Papageorgiou, K. Kostikas, T. Kiropoulos, E. Karetsi, G. Mpatavanis, and K. I. Gourgoulianis Increased Oxidative Stress in Exudative Pleural Effusions: A New Marker for the Differentiation Between Exudates and Transudates? Chest, November 1, 2005; 128(5): 3291 - 3297. [Abstract] [Full Text] [PDF]

				A. B. Carter, L. A. Tephly, S. Venkataraman, L. W. Oberley, Y. Zhang, G. R. Buettner, D. R. Spitz, and G. W. Hunninghake High Levels of Catalase and Glutathione Peroxidase Activity Dampen H2O2 Signaling in Human Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 43 - 53. [Abstract] [Full Text] [PDF]

				K. Psathakis, G. Papatheodorou, M. Plataki, P. Panagou, S. Loukides, N. M. Siafakas, and D. Bouros 8-Isoprostane, a Marker of Oxidative Stress, Is Increased in the Expired Breath Condensate of Patients With Pulmonary Sarcoidosis Chest, March 1, 2004; 125(3): 1005 - 1011. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				A. Emad and G. R. Rezaian Immunoglobulins and Cellular Constituents of the BAL Fluid of Patients With Sulfur Mustard Gas-Induced Pulmonary Fibrosis Chest, May 1, 1999; 115(5): 1346 - 1351. [Abstract] [Full Text] [PDF]

				P. MONTUSCHI, G. C. TONI, P. PAREDI, P. PANTELIDIS, R. M. du BOIS, S. A. KHARITONOV, and P. J. BARNES 8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1524 - 1527. [Abstract] [Full Text] [PDF]

				F. Mateos, J. H Brock, and J. L. Pérez-Arellano Iron metabolism in the lower respiratory tract Thorax, July 1, 1998; 53(7): 594 - 600. [Full Text]

				J. E. REPINE, A. BAST, I. LANKHORST, and The Oxidative Stress Study Gro Oxidative Stress in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 341 - 357. [Full Text]

				B. T. MOSSMAN and A. CHURG Mechanisms in the Pathogenesis of Asbestosis and Silicosis Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1666 - 1680. [Full Text]